Stockscreener 앱 받기
46.67
1.88%
0.86
전일 마감가:
$45.81
열려 있는:
$45.6
하루 거래량:
7,581
Relative Volume:
0.73
시가총액:
$N/A
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-0.09%
1개월 성능:
+8.48%
6개월 성능:
-7.88%
1년 성능:
-21.10%
1일 변동 폭
$45.60
$47.59
1주일 범위
$45.42
$47.59
52주 변동 폭
$33.77
$69.56
Proshares Ultra Nasdaq Biotechnology 2 X Shares Stock (BIB) Company Profile
명칭
Proshares Ultra Nasdaq Biotechnology 2 X Shares
전화
-
주소
-
BIB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BIB
Proshares Ultra Nasdaq Biotechnology 2 X Shares
|
47.59 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
304.40 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
618.30 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
621.26 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
240.21 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
547.94 | 124.43B | 0 | 0 | 0 | 0.00 |
Proshares Ultra Nasdaq Biotechnology 2 X Shares 주식(BIB)의 최신 뉴스
5 Best-Performing Leveraged ETFs of May - Nasdaq
Guide to the 10 Most Popular Leveraged ETFs - Nasdaq
8,890 Shares in ProShares Ultra Technology (NYSEARCA:ROM) Purchased by Jane Street Group LLC - Defense World
Jane Street Group LLC Boosts Stock Holdings in ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) - Defense World
5 Small-cap Biotech ETFs to Watch - Investing News Network
Best ETFs for Day Trading – Updated Lists and Statistics - Trade That Swing
Top Performing Leveraged/Inverse ETFs: 05/11/2025 - ETF Trends
ETF (Exchange Traded Fund): Rankings and news - marketscreener.com
All Markets & Instruments Available to Trade - Capital.com
Best Stocks Under $50 Right Now - Benzinga
Volatility ETFs Roar on Trump's New Tariff Woes - Nasdaq
Best Stocks Under $20 Right Now - Benzinga
ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Sees Large Drop in Short Interest - MarketBeat
ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) to Issue $0.13 Quarterly Dividend - MarketBeat
Short Interest in Alpha Technology Group Limited (NASDAQ:ATGL) Decreases By 17.1% - Defense World
ProShares UltraShort QQQ (NYSEARCA:QID) Stock Cross Above 200-Day Moving Average – Here’s What Happened - Defense World
Short Interest in AlphaTime Acquisition Corp (NASDAQ:ATMC) Decreases By 12.5% - Defense World
B. Riley Forecasts Strong Price Appreciation for Rigel Pharmaceuticals (NASDAQ:RIGL) Stock - Defense World
Short Interest in Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Expands By 21.3% - Defense World
VirnetX (NYSE:VHC) Stock Price Crosses Above 200-Day Moving Average – Should You Sell? - Defense World
Cloud Peak Energy (OTCMKTS:CLDPQ) Stock Price Passes Above 200 Day Moving Average – Time to Sell? - Defense World
MicroVision (NASDAQ:MVIS) Shares Pass Above 200 Day Moving Average – Here’s What Happened - Defense World
Pacific Drilling (OTCMKTS:PACDQ) Shares Pass Above 200 Day Moving Average – What’s Next? - Defense World
Helpport AI (NASDAQ:HPAI) Trading Down 4.8% – Here’s Why - Defense World
BranchOut Food Inc. (NASDAQ:BOF) Sees Large Increase in Short Interest - Defense World
Short Interest in Better Home & Finance Holding (NASDAQ:BETR) Declines By 12.5% - Defense World
Private Advisor Group LLC Sells 11,056 Shares of First Bank (NASDAQ:FRBA) - Defense World
Saratoga Resources (OTCMKTS:SARA) Share Price Crosses Above 200-Day Moving Average – Here’s What Happened - Defense World
Hull Tactical US ETF (NYSEARCA:HTUS) Shares Sold by Private Advisor Group LLC - Defense World
BriaCell Therapeutics Corp. (NASDAQ:BCTXW) Short Interest Update - Defense World
Private Advisor Group LLC Grows Stock Holdings in JPMorgan BetaBuilders U.S. Aggregate Bond ETF (NYSEARCA:BBAG) - Defense World
ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) Short Interest Update - Defense World
Short Interest in ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Grows By 154.5% - Defense World
Global X Blockchain & Bitcoin Strategy ETF (NASDAQ:BITS) Short Interest Update - Defense World
Best-Performing Leveraged ETFs of Last Week - Nasdaq
ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Stock Pass Above 50-Day Moving AverageWhat's Next? - MarketBeat
Why 3x ETFs Are Riskier Than You Might Think - Investopedia
Stock Market Movers Today • Top Gainers & Losers - Benzinga
DeepSeek AI Model Sends Shockwaves Through Nvidia, Slams ETFs - Benzinga
SPDR S&P Biotech ETF (XBI): How to Buy - The Motley Fool
4 Aggressive ETF Strategies - Investopedia
Top Performing Leveraged/Inverse ETFs: 11/17/2024 - ETF Trends
5 Small-cap Biotech ETFs to Watch (Updated 2024) - Nasdaq
5 Best Leveraged ETFs of the First Nine Months of 2024 - Yahoo Finance
Brad Jacobs' QXO Eyes $9.4 Billion Rexel Takeover - Finimize
Semiconductor ETFs Take A Beating, Dragged Lower By Nvidia, AMD, and Broadcom Stocks - Yahoo Finance
Nvidia ETFs Split In Pre-Market After Jensen Huang-Led Chip Giant Exceeds Q2 Expectations - Benzinga
How To Simply Beat The S&P 500 Over The Long Run (But Why We Don't Do It) - Seeking Alpha
Best 2x Leveraged ETFs - Benzinga
UVXY: The VIX Is Too Low (BATS:UVXY) - Seeking Alpha
BITU May Be Too Risky At 2x Leverage - Seeking Alpha
Proshares Ultra Nasdaq Biotechnology 2 X Shares (BIB) 재무 분석
Proshares Ultra Nasdaq Biotechnology 2 X Shares (BIB)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
1.07%
0.82%
자본화:
|
볼륨(24시간):